ECM
ABBV icon

EMC Capital Management’s AbbVie ABBV Stock Holding History

EMC Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
+1,044
New +$225K 0.11% 29
2025
Q4 		$228K Buy
1,036
+7
+0.7% +$1.59K 0.1% 60
2025
Q3 		$238K Buy
1,029
+9
+0.9% +$1.83K 0.11% 70
2025
Q2 		$189K Hold
1,020
– – 0.1% 84
2025
Q1 		$213K Hold
1,020
– – 0.13% 141
2024
Q4 		$181K Hold
1,020
– – 0.1% 171
2024
Q3 		$203K Hold
1,020
– – 0.13% 158
2024
Q2 		$170K Hold
1,020
– – 0.1% 183
2024
Q1 		$184K Hold
1,020
– – 0.11% 183
2023
Q4 		$158K Buy
1,020
+10
+1% +$1.46K 0.11% 174
2023
Q3 		$150K Buy
+1,010
New +$148K 0.11% 170

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EMC Capital Management's ABBV Position: Q2 2026 in Review

EMC Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 1,044 shares worth $267K. The stake represents 0.11% of the portfolio and ranks #29 among its holdings. This is a return to the name: EMC Capital Management previously reported a position in ABBV as recently as Q4 2025.

EMC Capital Management first reported a position in ABBV in Q3 2023 and has held it in 11 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EMC Capital Management held 1,044 shares of AbbVie worth $267K as of Q2 2026.
  • AbbVie was a new EMC Capital Management position in Q2 2026.
  • AbbVie made up 0.11% of EMC Capital Management's portfolio in Q2 2026, its #29 holding.
  • EMC Capital Management first reported a position in AbbVie in Q3 2023 and has held it in 11 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EMC Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.